Veralto Corporation (NYSE:VLTO) Shares Acquired by Advisors Preferred LLC

Advisors Preferred LLC increased its stake in Veralto Corporation (NYSE:VLTO - Free Report) by 73.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,251 shares of the company's stock after buying an additional 3,066 shares during the quarter. Advisors Preferred LLC's holdings in Veralto were worth $708,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC increased its stake in shares of Veralto by 16.1% during the fourth quarter. Brighton Jones LLC now owns 3,459 shares of the company's stock valued at $352,000 after buying an additional 479 shares during the period. Proficio Capital Partners LLC purchased a new position in shares of Veralto during the fourth quarter valued at $84,000. LPL Financial LLC increased its stake in shares of Veralto by 4.7% during the fourth quarter. LPL Financial LLC now owns 395,336 shares of the company's stock valued at $40,265,000 after buying an additional 17,633 shares during the period. Vanguard Group Inc. increased its stake in shares of Veralto by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 29,347,185 shares of the company's stock valued at $2,989,011,000 after buying an additional 146,234 shares during the period. Finally, CoreFirst Bank & Trust purchased a new position in shares of Veralto during the fourth quarter valued at $88,000. Hedge funds and other institutional investors own 91.28% of the company's stock.

Veralto Stock Performance

Shares of Veralto stock traded up $0.11 on Friday, reaching $103.38. 1,019,417 shares of the stock were exchanged, compared to its average volume of 1,387,994. The company has a quick ratio of 1.92, a current ratio of 2.19 and a debt-to-equity ratio of 1.14. Veralto Corporation has a twelve month low of $83.86 and a twelve month high of $115.00. The firm has a market capitalization of $25.62 billion, a price-to-earnings ratio of 29.54, a PEG ratio of 4.07 and a beta of 0.91. The business has a 50 day moving average price of $100.78 and a two-hundred day moving average price of $98.49.

Veralto (NYSE:VLTO - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.08. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.28 billion. Veralto had a return on equity of 45.63% and a net margin of 16.56%. Veralto's quarterly revenue was up 6.9% on a year-over-year basis. During the same period last year, the business earned $0.84 earnings per share. Analysts anticipate that Veralto Corporation will post 3.66 earnings per share for the current fiscal year.

Veralto Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date of this dividend is Monday, June 30th. Veralto's dividend payout ratio (DPR) is presently 12.57%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Royal Bank Of Canada raised their price target on Veralto from $103.00 to $104.00 and gave the company a "sector perform" rating in a research note on Thursday, May 1st. Citigroup reduced their price objective on shares of Veralto from $116.00 to $100.00 and set a "neutral" rating for the company in a research note on Monday, April 14th. Robert W. Baird raised their target price on shares of Veralto from $105.00 to $106.00 and gave the company a "neutral" rating in a research note on Thursday, May 1st. Northcoast Research started coverage on Veralto in a report on Tuesday, May 6th. They set a "buy" rating and a $110.00 price objective for the company. Finally, Stifel Nicolaus upped their target price on Veralto from $104.00 to $116.00 and gave the company a "buy" rating in a research report on Monday. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $111.18.

Insiders Place Their Bets

In other news, SVP Melissa Aquino sold 31,689 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $93.67, for a total value of $2,968,308.63. Following the completion of the sale, the senior vice president directly owned 17,434 shares in the company, valued at $1,633,042.78. The trade was a 64.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Jennifer Honeycutt sold 10,418 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $95.00, for a total value of $989,710.00. Following the sale, the chief executive officer owned 106,219 shares of the company's stock, valued at $10,090,805. The trade was a 8.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,913 shares of company stock valued at $4,339,370. 0.36% of the stock is owned by insiders.

About Veralto

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.